xmlui.themes.about.link
Departamento de Medicina y Psiquiatría: Envíos recientes
Mostrando ítems 281-300 de 1349
-
Fibroblast growth factor 21 is a hepatokine involved in MASLD progression
(Wiley-Blackwell, 2024) -
SEOM-GEMCAD-TTD clinical guidelines for the management of hepatocarcinoma patients (2023)
(Springer-Verlag Italia, 2024) -
Processing speed in first episode of psychosis and first-degree relatives: a candidate endophenotype of spectrum schizophrenia disorders
(American Psychological Association, 2024) -
Use of Tirzepatide in adults with type 2 diabetes mellitus: scientifc evidence and practical aspects
(Springer, 2024-04-09) -
Risk loci involved in giant cell arteritis susceptibility: a genome-wide association study
(Elsevier, 2024-05-08) -
Osteopontin as a biomarker in interstitial lung diseases
(MDPI AG, 2024-05-16) -
Effect of sibutramine on cardiovascular outcomes in overweight and obese subjects
(Boston, Massachusetts Medical Society, 2010) -
Nilotinib versus imatinib for newly diagnosed chronic myeloid leukemia
(Boston, Massachusetts Medical Society, 2010) -
Lung transplantation for emphysema: only emphysema or something else?
(Pioneer Bioscience Publishing Company, 2023) -
Osteomesopyknosis associated with a novel ALOX5 variant that impacts the RANKL pathway
(Wiley-Blackwell, 2024) -
Brave new world: expanding home care in stem cell transplantation and advanced therapies with new technologies
(Frontiers Research Foundation, 2024)







